What is the current share price of Divi's Laboratories Limited (DIVISLAB)?

As of the latest market update, Divi's Laboratories Limited (DIVISLAB) is trading at ₹6,638. The stock has moved 0.26% down in the recent session.

What is the technical sentiment for DIVISLAB stock?

Based on our proprietary technical analysis, the current signal for DIVISLAB is "NEUTRAL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Divi's Laboratories Limited?

Divi's Laboratories Limited has seen a 52-week high of ₹7,071.5 and a 52-week low of ₹5,636.5. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Divi's Laboratories Limited belong to?

Divi's Laboratories Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of DIVISLAB?

Divi's Laboratories Limited (DIVISLAB) has a market capitalization of approximately ₹1.76L Cr. This classifies it as a large cap stock in the Indian market.

DIVISLAB

NSEF&O

Divi's Laboratories Limited (LARGE CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹6,638.00

17.50 (0.26%)

Medium VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹1.76L Cr

LARGE CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

68.8

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹5,636.5+17.8%

52W High₹7,071.5-6.1%

Current Price

₹6,638.00

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹5,310.40

Upper Circuit₹7,965.60

Reference Price

₹6,638.00

Investment Checklist

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹6732.5

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹6871.0

Volume divergence: Bearish (price up, volume down)

EMA(9) Crossover: Price crossed below EMA(9): Fresh bearish weakness signal.

EMA(20) Crossover: Price crossed below EMA(20): Fresh bearish weakness signal.

Technical Analysis

Analysis from 2026-06-12

Confidence

44%

Trend

NEUTRAL

Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)

EMA20

6652.6

EMA50

6543.22

EMA200

6402.51

Price Action

UPTREND

BULLISH

Higher Highs6

Higher Lows6

Lower Highs3

Lower Lows3

Support & Resistance Levels

Resistance (Above)

₹6752.67

₹6911.67

₹7071.50

Support (Below)

₹6576.83

₹6461.67

₹6307.71

₹5922.25

₹5644.75

Volume Analysis

TrendDECREASING

Change-14.40%

Unusual VolumeNo

Divergence Detected

Bearish (price up, volume down)

Stop Loss Levels

Fixed Risk

1% Risk₹6571.62

3% Risk₹6438.86

5% Risk₹6306.10

7% Risk (Custom)

₹6173.34

Technical Levels

1x ATR (Volatility)₹6481.01

2x ATR (Swing)₹6324.02

3x ATR (Trend)₹6167.03

Immediate Support₹6576.83

Moving Averages

EMA 50 (Trend)₹6543.22

EMA 200 (Long-term)₹6402.51

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹2,319 Cr	₹2,550 Cr	₹2,410 Cr	₹2,604 Cr
Net Profit	₹589 Cr	₹662 Cr	₹545 Cr	₹583 Cr
EPS	₹22.20	—	₹20.49	₹21.98
Operating Profit	₹825 Cr	₹972 Cr	₹848 Cr	₹904 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%
BIOCON	Biocon Limited	₹419.00	+0.73%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
25 Jul 2025	Dividend - Rs 30 Per Share	DIVIDEND
02 Aug 2024	Dividend - Rs 30 Per Share	DIVIDEND
11 Aug 2023	Dividend - Rs 30 Per Share	DIVIDEND
11 Aug 2022	Dividend - Rs 30 Per Share	DIVIDEND
17 Aug 2021	Dividend - Rs 20 Per Share	DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
11 Jun 2026	Updates
04 Jun 2026	Copy of Newspaper Publication
29 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
25 May 2026	Copy of Newspaper Publication
25 May 2026	Outcome of Board Meeting

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
23 May 2026	Financial Results/Dividend
23 May 2026	Board Meeting Intimation	XBRL
11 Feb 2026	Financial Results
11 Feb 2026	Board Meeting Intimation	XBRL
07 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for DIVISLAB

View All

positive

Business Standard - Markets 19d ago

Divi's Labs slips 3% on margin worries; analysts positive on growth outlook

In the March quarter, Divi's Laboratories reported net profit at ₹751 crore, as compared to ₹662 crore a year ago, up 13.4 per cent year-on-year (Y-o-Y)

DIVISLABMOGSECFinancial ServicesHealthcare

Read full story

Divi's Laboratories analysts remain divided on prospects after Q4 results; Check key triggers & risks

negative

CNBC TV18 - Markets 19d ago

Divi's Laboratories analysts remain divided on prospects after Q4 results; Check key triggers & risks

Kotak Institutional Equities, who is bearish on Divi's Laboratories, said that the stock's current valuations of 49 times its estimated price-to-earnings ratio for FY28, is already pricing in growth potential.

CURRENTDIVISLABConstructionHealthcare

Read full story

Six pharma stocks that should be on your radar today over various news triggers

negative

CNBC TV18 - Markets 19d ago

Six pharma stocks that should be on your radar today over various news triggers

It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:

DIVISLABFORTISGLENMARKHCGHCG-REHEALTHCARELUPINNHNIDANTRUSTFinancial ServicesHealthcare

Read full story

DIVISLAB

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for DIVISLAB

Divi's Labs slips 3% on margin worries; analysts positive on growth outlook

Divi's Laboratories analysts remain divided on prospects after Q4 results; Check key triggers & risks

Six pharma stocks that should be on your radar today over various news triggers

Frequently Asked Questions

What is the current share price of Divi's Laboratories Limited (DIVISLAB)?

What is the technical sentiment for DIVISLAB stock?

What is the 52-week high and low for Divi's Laboratories Limited?

Which sector does Divi's Laboratories Limited belong to?

What is the market capitalization of DIVISLAB?